SHR-1210
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer (NCT04797507) | Peking Union Medical College Hospital | 2021-03-01 |
| Apatinib Plus SHR1210 in Advanced Mucosal Melanoma (NCT03986515) | Henan Cancer Hospital | 2019-06-04 |
Track SHR-1210 automatically
Every clearance here is in the API, with alerts when new ones post.